Medicare GLP-1 Coverage at $50: Your Step-by-Step Guide

What Is the Medicare GLP-1 Bridge?

The Bridge is a temporary CMS demonstration for eligible weight-management prescriptions, running through December 31, 2027. It operates outside the Part D benefit and payment process. Part D plans do not need to opt in, but beneficiaries must be enrolled in an eligible plan type.[1]

The Part D deductible does not apply. The $50 copay does not count toward Part D true out-of-pocket costs (TrOOP), and Extra Help does not reduce it.[2]

Do I Qualify?

1. Confirm Your Part D Plan Type

Eligible enrollment includes a standalone prescription drug plan (PDP), a Medicare Advantage coordinated care plan with drug coverage (HMO, HMOPOS, or local/regional PPO), Special Needs Plans, employer/union group waiver plans, and LI NET. People with both Medicare and Medicaid may qualify.[1]

Private fee-for-service plans, section 1876 cost contract plans, section 1833 health care prepayment plans, PACE, fallback plans, and religious fraternal benefit plans are excluded unless the person also has a standalone PDP, as applicable. If uncertain, ask your plan, 1-800-MEDICARE, or your State Health Insurance Assistance Program (SHIP) about your enrollment; the Bridge itself is not a Part D plan.[1]

2. Review the Exact Clinical Criteria

CMS requires age 18 or older and a prescription to reduce excess weight and maintain weight reduction, with ongoing structured nutrition and physical activity consistent with the FDA-approved label. The prescriber must attest to one of these pathways, using BMI and qualifying conditions at initiation of GLP-1 therapy:[1]

These are specific CMS criteria—not “any weight-related condition.” The initiation rule also applies to people who began treatment before Medicare enrollment or before July 1, 2026. Bring older clinical records if available; do not assume that a lower current BMI rules you out.[1]

3. Check Whether the Prescription Belongs Under Part D

CMS excludes beneficiaries with type 2 diabetes, moderate-to-severe obstructive sleep apnea, or the relevant noncirrhotic MASH diagnosis because these indications have a Part D coverage route. The provider FAQ clarifies the MASH diagnosis as involving moderate-to-advanced liver scarring consistent with F2–F3 fibrosis. Prescribers must assess the actual diagnoses accurately; good control on treatment does not automatically mean a diagnosis no longer applies.[1]

Cardiovascular disease needs a separate distinction: prior heart attack, stroke, or symptomatic peripheral artery disease can meet the Bridge's BMI ≥27 pathway for weight management. But a prescription intended to reduce major cardiovascular events goes to Part D, even if weight management is also a goal. Part D eligibility for an indication does not guarantee every product is covered; check the plan's formulary and authorization rules.[1]

Prior Authorization: Pharmacy Claim Before Prescriber Request

Step 1: Schedule an Appointment

Ask your prescriber whether GLP-1 treatment is appropriate and which coverage route applies. Bring:

• Your Medicare card and Part D plan information
• Current medicines and supplements
• Weight and diagnosis records from when GLP-1 therapy began, if already taking one
• Questions about treatment risks, nutrition, and affordability

Step 2: The Prescriber Sends the Prescription

If appropriate, the prescriber sends the prescription to the pharmacy. CMS recommends a diagnosis code and a note directing eligible prescriptions to the Bridge to help routing, but does not require that annotation. A Part D denial is not required before a Bridge claim.[1]

Step 3: The Pharmacy Submits the Bridge Claim First

The pharmacy needs your Medicare Number and submits the claim to establish eligibility. Do not have the prescriber submit prior authorization first: CMS says this produces a “patient not found” error when no pharmacy claim has established eligibility.[1][2]

Step 4: The Prescriber Completes Prior Authorization

The pharmacy sends the request electronically or by fax, typically within 24–72 hours. If no request arrives after 72 hours, the prescriber can use the fax form linked on the CMS provider page, after the pharmacy claim step.[1]

CMS says the approval or denial is sent to the prescriber through the electronic portal or fax within 72 hours of submission and mailed to the patient. This is not a promise of approval or same-day dispensing. Incorrect or additional information can be submitted on a new form; CMS says there is no Bridge appeals process.[1]

Step 5: Confirm the Approved Fill and Refills

After approval, the pharmacy may need to resubmit the claim. The $50 copay applies to an eligible 28- or 30-day supply. Partial, 60-day, and 90-day fills are not available. CMS allows pharmacy point-of-sale vacation overrides, but not overrides for lost or stolen medication.[2]

Prior authorizations are valid through December 31, 2027; switching to another covered GLP-1 drug requires a new authorization. Continuing eligibility still matters: a later Part D GLP-1 fill or a move to an ineligible plan type can cause a Bridge refill rejection.[2]

What Drugs and Costs Are Covered

CMS lists these products; the pharmacy should verify the current National Drug Code (NDC) against the CMS list.[1]

Foundayo is orforglipron, not a cagrilintide/semaglutide combination. This insurance checklist does not provide strengths or dosing schedules; the prescriber and pharmacist should confirm the actual product and instructions.[5]

The $50 is the drug copay, not a promise that every treatment-related expense is included. For example, CMS says Zepbound KwikPen needles are not covered by the Bridge and should not be billed to the patient's Part D plan. Ask about their separate cost before filling.[2]

Coupons and discount programs cannot be applied to Bridge claims, and the Bridge does not coordinate benefits with other payers. Direct member reimbursement is not available. Do not pay cash assuming the Bridge will reimburse you later.[2]

Pharmacy Guidance: Where to Fill Your Prescription

CMS says pharmacies do not need to opt in. That does not establish that a particular branch stocks your medicine or has correctly routed your claim. Call your preferred pharmacy rather than relying on a “confirmed chain” list.[2]

Before the first fill, ask the pharmacy to confirm:

1. It can process a Medicare GLP-1 Bridge claim using your Medicare Number.
2. The prescribed formulation and NDC are included.
3. The claim was sent before the prescriber prior authorization.
4. Any required authorization is active and the final claim shows the expected $50 copay.

For routing problems, CMS lists the pharmacy help desk at 844-673-0910. The prescriber call center is 855-273-0102, Monday–Friday, 8 a.m.–7 p.m. Eastern. These are different from 1-800-MEDICARE, which can help with general Medicare questions.[1][2]

What Happens After 2027?

CMS currently lists December 31, 2027 as the end date. It describes BALANCE as a potential future Part D implementation, not promised permanent coverage or a confirmed lower copay. The provider FAQ says BALANCE is not launching in 2027; it does not establish the speculative 2028/2029 dates or income-based prices previously stated here.[1]

Ask your care team about continuity of care before coverage ends or changes. Do not change doses or stop treatment based on a predicted policy change. Check the CMS provider guidance for updates.

For older adults and caregivers, our GLP-1 safety for seniors guide covers nutrition, medication review, and monitoring discussions.

This content is informational, not medical or insurance advice. CMS guidance was checked September 13, 2026. Coverage rules can change; verify your specific prescription and eligibility with your prescriber, pharmacy, and Medicare plan.

Sources

• [1] cms.gov
• [2] cms.gov
• [5] pi.lilly.com